Answers are grounded in this paper and cite their sources.
Background and Aim Haemorrhage is a leading cause of trauma-related morbidity and mortality. The Advanced Trauma Life Support (ATLS) system classifies haemorrhagic shock into four categories using triage vital signs (TVS), with treatment recommendations for each class. However, TVS are limited as indicators of tissue perfusion and poor predictors of shock severity, often resulting in under-triage and delayed resuscitation. Biomarkers such as serum lactate (SL) and base deficit (BD), which directly reflect hypoperfusion, have demonstrated greater sensitivity and specificity in detecting early stages of haemorrhagic shock. This review critically examined the literature on the relationship between SL, BD, and TVS in predicting outcomes in adult trauma patients. Method A systematic search of PubMed, EMBASE, Cochrane Library, and Web of Science was conducted for studies published between January 2000 and December 2020. Eligibility criteria were predefined, risk of bias was assessed using the Newcastle-Ottawa Scale, and evidence quality was evaluated with the GRADE framework. Due to heterogeneity, a narrative synthesis was performed. Results Seven observational studies were included from an initial pool of 3,338. While both TVS and biomarkers correlated with morbidity and mortality, SL and BD consistently provided superior predictive value. Shock classification based on SL or BD offered clearer guidance for triage, resuscitation, and prognostication compared to the ATLS TVS-based system. Conclusions Biomarkers such as SL and BD enhance early recognition and management of haemorrhagic shock. Patients with BD >6 or SL ≥2.5 should be prioritized for higher-level care and aggressive resuscitation to reduce adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Salawu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: